Assessment of Binocular Vision Function With Neos™ (ROCKET)
NCT07920263, Not applicable, Not yet recruiting, machineMD AG
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Assessment of Binocular Vision Function With Neos™ (ROCKET) | ClinicalTrials.gov |
| NCT number | NCT07920263 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 184 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | machineMD AG | ClinicalTrials.gov |
| Conditions | Binocular Vision Dysfunction | ClinicalTrials.gov |
| Interventions | Manual binocularity assessment | ClinicalTrials.gov |
| First posted | 2026-11-05 | ClinicalTrials.gov |
| Last updated | 2026-11-05 | ClinicalTrials.gov |
Registered outcomes 3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Sensitivity and Specificity of neos™ for Detecting Sensory Fusion | During the single study visit (approximately 60 minutes). | Sensitivity and specificity of the neos™ sensory fusion classification (present/absent) compared with the clinical reference classification. Reference sensory fusion is present when binocular single perception is demonstrated using Bagolini striated lenses or Worth 4-Dot testing. Performance is calculated from paired classifications and reported with two-sided 95% exact Clopper-Pearson confidence intervals. | ClinicalTrials.gov |
| Primary | Sensitivity and Specificity of neos™ for Detecting Stereopsis | During the single study visit (approximately 60 minutes). | Sensitivity and specificity of the neos™ stereopsis classification (present/absent) compared with standard clinical stereotesting. For both methods, stereopsis is classified as present when stereoscopic disparity of 600 arcseconds or finer is detected. Performance is calculated from paired classifications and reported with two-sided 95% exact Clopper-Pearson confidence intervals. | ClinicalTrials.gov |
| Primary | Sensitivity and Specificity of neos™ for Detecting Central Suppression | During the single study visit (approximately 60 minutes). | Sensitivity and specificity of the neos™ central (foveal) suppression classification (present/absent) compared with the clinical reference classification. The reference uses a prespecified hierarchical rule: suppression is absent when stereopsis or sensory fusion is present. When both are absent, suppression is present if clinical testing demonstrates failure to perceive input from one eye; otherwise, it is absent. Performance is reported with two-sided 95% exact Clopper-Pearson confidence intervals. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)